Literature DB >> 27102189

How the MDGs gave up on measuring access to medicines.

Dzintars Gotham1, Kristine H Onarheim2, Melissa J Barber3.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27102189     DOI： 10.1016/S2214-109X(16)00066-8

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  5 in total

1.  Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis.

Authors:  Sakthivel Selvaraj; Habib Hasan Farooqui; Aashna Mehta
Journal:  BMJ Open       Date:  2019-01-24       Impact factor: 2.692

2.  Inappropriate use of medicines and associated factors in Brazil: an approach from a national household survey.

Authors:  Vera Lucia Luiza; Luiz Villarinho Pereira Mendes; Noemia Urruth Leão Tavares; Andrea Damaso Bertoldi; Andréia Turmina Fontanella; Maria Auxiliadora Oliveira; Mônica Rodrigues Campos
Journal:  Health Policy Plan       Date:  2019-12-01       Impact factor: 3.344

3.  Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey.

Authors:  Phillip Cohen; Paola Friedrich; Catherine Lam; Sima Jeha; Monika L Metzger; Ibraham Qaddoumi; Paula Naidu; Lane Faughnan; Carlos Rodriguez-Galindo; Nickhill Bhakta
Journal:  J Glob Oncol       Date:  2018-12

4.  Universal access to essential medicines as part of the right to health: a cross-national comparison of national laws, medicines policies, and health system indicators.

Authors:  Katrina Perehudoff
Journal:  Glob Health Action       Date:  2020-12-31       Impact factor: 2.640

5.  Missing data on accessibility of children's medicines.

Authors:  Iris R Joosse; Aukje K Mantel-Teeuwisse; Veronika J Wirtz; Fatima Suleman; Hendrika A van den Ham
Journal:  Bull World Health Organ       Date:  2022-09-02       Impact factor: 13.831
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.